CTX-M-3 type beta-lactamase producing Shigella sonnei isolates from pediatric bacillary dysentery cases

Japanese Journal of Infectious Diseases

Volumn 61, Issue 2, 2008, Pages 135-137

  Acikgoz, Ziya Cibali ^a   Eser, Ozgen Koseoglu ^b   Kocagöz, Sesin ^c  

^a FATIH UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c YEDITEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BACTERIAL PROTEIN; BETA LACTAMASE; BETA LACTAMASE CTX M 3; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; OFLOXACIN; PROTEIN BLA; SULFAMETHOXAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL METABOLISM; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISK DIFFUSION; DNA SEQUENCE; ENZYME ANALYSIS; ENZYME SYNTHESIS; FEMALE; HUMAN; ISOELECTRIC FOCUSING; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; SHIGELLA SONNEI; SHIGELLOSIS; TEST STRIP;

ANTI-INFECTIVE AGENTS; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; ISOELECTRIC FOCUSING; MALE; POLYMERASE CHAIN REACTION; SHIGELLA SONNEI; TREATMENT OUTCOME; TURKEY;

EID: 43449121250     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Canton, R. and Coque, T.M. (2006): The CTX-M beta-lactamase pandemic. Curr. Opinion Microbiol., 9, 466-475.
2. Jarlier, V., Nicolas, M.H., Fournier, G., et al. (1998): Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis., 10, 867-878.
3. Clinical and Laboratory Standards Institute (2006): Performance standards for antimicrobial susceptibility testing. 16th informational supplement. CLSI document M100-S16. Clinical and Laboratory Standards Institute, Wayne, Pa.
4. Eckert, C., Gautier, V., Saladin-Allard, M., et al. (2004): Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob. Agents Chemother., 48, 1249-1255.
5. Tenover, F.C., Raney, P.M., Williams, P.P., et al. (2003): Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during project ICARE. J. Clin. Microbiol., 41, 3142-3146.
6. Edelstein, M., Pimkin, M., Palagin, I., et al. (2003): Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob. Agents Chemother., 47, 3724-3732.
7. Paterson, D.L., Hujer, K.M., Hujer, A.M., et al. (2003): Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M type beta-lactamases. Antimicrob. Agents Chemother., 47, 3554-3560.
8. Kim, J., Lim, YM., Rheem, I., et al. (2005): CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea. FEMS Microbiol. Lett., 245, 93-98.
9. Altschul, S.F., Madden, T.L., Schaffer, A.A., et al. (1997): Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res., 25, 3389-3402.
10. Shibata, N., Kurokawa, H., Doi, Y., et al. (2005): PCR classification of CTX-M-tyqe beta-lactamase genes identified in clinically isolated gram-negative bacilli in Japan. Antimicrob. Agents Chemother., 50, 791-795.
11. Liu, RY, Lau, Y.J., Hu, B.S., et al. (1995): Analysis of clonal relationships among isolates of Shigella sonnei by different molecular typing methods. J. Clin. Microbiol., 33, 1779-1783.
12. Brian, M.J., Van, R., Townsend, I., et al. (1993): Evaluation of the molecular epidemiology of an outbreak of multiply resistant Shigella sonnei in a day-care center by using pulsed-field gel electrophoresis and plasmid DNA analysis. J. Clin. Microbiol., 31, 128-133.
13. Tenover, F.C., Arbeit, R.D., Goering, R.V., et al. (1995): Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 33, 2233-2239.
14. Livermore, D.M., Canton, R., Gniadkowski, M., et al. (2007): CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother., 59, 165-174.
15. Aharned, J. and Kundu, M. (1999): Molecular characterisation of the SHV-11 beta-lactarnase of Shigella dysenteriae. Antimicrob. Agents Chemother., 43, 2081-2083.
16. Fortineau, N., Naas, T., Gaillot, O., et al. (200 1): SHV-type extended-spectrum beta-lactamase in a Shigella sonnei clinical isolate. J. Antimicrob. Chemother., 47, 685-688.
17. Pai, H., Choi, E.H., Lee, H.J., et al. (2001): Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J. Clin. Microbiol., 39, 3747-3749.
18. Radice, M., Gonzales, C., Power, P., et al. (2001): Third generation cephalosporin resistance in Shigella sonnei, Argentina. Emerg. Infect. Dis., 7, 442-443.
19. Rahman, M., Shoma, S., Rashid, H., et al. (2004): Extended-spectrum beta-lactamase-mediated third-generation cephalosporin resistance in Shigella isolates in Bangladesh. J. Antimicrob. Chemother., 54, 846-847.
20. Kim, S., Kim, J., Kang, Y., et al. (2004): Occurrence of extended-spectrum β-lactamases in members of the genus Shigella in the Republic of Korea. J. Clin. Microbiol., 42, 5264-5269.
21. Cheung, T.K., Chu, Y.W., Tsang, G.K., et al. (2005): Emergence of CTX-M-type beta-lactam resistance in Shigella spp. in Hong Kong. Int. J. Antimicrob. Agents, 25, 350-352.
22. Lartigue, M.F., Poirel, L., Decousser, J.W., et al. (2005): Multidrug-resistant Shigella sonnei and Salmonella enterica serotype Typhimurium. isolates producing CTX-M beta-lactamases as causes of community-acquired infection in France. Clin. Infect. Dis., 40, 1069-1070.
23. Huang, I.F., Chiu, C.H., Wang, M.H., et al. (2005): Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: first report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei. J. Clin. Microbiol., 43, 2608-2612.
24. Andres, P., Petroni, A., Faccone, D., et al. (2005): Extended-spectrum beta-lactamases in Shigella flexneri from Argentina: first report of TOHO-1 outside Japan. Int. J. Antimicrob. Agents, 25, 501-507.
25. Vasilev, V., Japheth, R., Yishai, R., et al. (2007): Extended-spectrum beta-lactamase-producing Shigella strains in Israel, 2000-2004. Eur. J. Clin. Microbiol. Infect. Dis., 26, 189-194.
26. Acikgoz, Z.C., Gulay, Z., Bicmen, M., et al. (2003): CTX-M-3 extended-spectrum beta-lactamase in a Shigella sonnei clinical isolate: first report from Turkey. Scand. J. Infect. Dis., 35, 503-505.
27. Talukder, K.A., Khajanchi, B.K., Islam, M.A., et al. (2006): Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1. Curr. Microbiol., 52, 108-111.